FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY

EIN: 841363353 501(c)(3) Medical Research

OMAHA, NE

Total Revenue
$7,178,506
Total Expenses
$6,341,397
Total Assets
$3,752,677
Net Assets
$3,752,677
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1996
Legal Domicile
CO
Principal Officer
LINDA MILLER MPA
Phone
4029207003
Tax Period
2024-01-01 to 2024-12-31

FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY, founded in 1996, is a community nonprofit in the Medical Research sector that reported $7.2M in total revenue in fiscal year 2024. Revenue surged 31% from the prior year, signaling strong growth momentum. Expenses of $6.3M left a modest 12% surplus.

Mission

FACT IS A NON-PROFIT CORPORATION FOUNDED TO IMPROVE THE QUALITY OF CELLULAR THERAPY THROUGH PEER-DEVELOPED STANDARDS, EDUCATION AND ACCREDITATION FOR THE BENEFIT OF PATIENTS.

Program Service Accomplishments

Program 1
Expenses: $2,764,178 Revenue: $5,991,537

ACCREDITATION - THE ORGANIZATION ADMINISTERS THE ACCREDITATION PROCESS FOR CELLULAR THERAPY PROGRAMS AND CORD BLOOD BANKS AT RESEARCH AND MEDICAL INSTITUTIONS THAT DESIRE TO OBTAIN THE ACCREDITATION...

Read more

ACCREDITATION - THE ORGANIZATION ADMINISTERS THE ACCREDITATION PROCESS FOR CELLULAR THERAPY PROGRAMS AND CORD BLOOD BANKS AT RESEARCH AND MEDICAL INSTITUTIONS THAT DESIRE TO OBTAIN THE ACCREDITATION DESIGNATION FOR THEIR PROGRAMS.

Program 2
Expenses: $362,160 Revenue: $196,306

TRAINING & EDUCATION - THE ORGANIZATION PROVIDES FEE-BASED TRAINING AND EDUCATION FOR ACCREDITED PROGRAMS TO ASSIST THEM IN KEEPING UP-TO-DATE WITH NEW AND REVISED STANDARDS FOR THEIR PROGRAMS. THIS...

Read more

TRAINING & EDUCATION - THE ORGANIZATION PROVIDES FEE-BASED TRAINING AND EDUCATION FOR ACCREDITED PROGRAMS TO ASSIST THEM IN KEEPING UP-TO-DATE WITH NEW AND REVISED STANDARDS FOR THEIR PROGRAMS. THIS MAY INCLUDE SEMINARS AND DISTANCE LEARNING FOR ACCREDITED PROGRAMS. TO AID PROGRAMS IN EMERGING ECONOMIES, EDUCATIONAL SESSIONS ARE PROVIDED AT NO EXPENSE. TRAINING AND EDUCATION IS ALSO PROVIDED TO FACT'S INSPECTORS AT NO COST TO THE VOLUNTEERS.

Program 3
Expenses: $157,796 Revenue: $6,150

STANDARDS DEVELOPMENT - THE ORGANIZATION RESEARCHES AND DEVELOPS THE APPROPRIATE STANDARDS FOR DESIGNATED PROGRAMS TO ENSURE THAT ALL ACCREDITED CELLULAR THERAPY PROGRAMS AND CORD BLOOD BANKS ARE...

Read more

STANDARDS DEVELOPMENT - THE ORGANIZATION RESEARCHES AND DEVELOPS THE APPROPRIATE STANDARDS FOR DESIGNATED PROGRAMS TO ENSURE THAT ALL ACCREDITED CELLULAR THERAPY PROGRAMS AND CORD BLOOD BANKS ARE ADHERING TO RIGOROUS STANDARDS. THE ORGANIZATION IS VESTED IN ASSISTING PROGRAMS WITH PROVIDING THE HIGHEST STANDARD OF CARE IN THE FIELD OF CELLULAR THERAPY, WHICH IS INCORPORATED INTO THE DEVELOPED STANDARDS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $500,000
Program Service Revenue $6,666,377
Investment Income $12,129
Other Revenue $0
TOTAL REVENUE $7,178,506

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $3,566,942
Other Expenses $6,341,397
TOTAL EXPENSES $6,341,397

Year-over-Year Comparison

2024 2023 Change
Revenue $7,178,506 $5,475,747 +0.3%
Expenses $6,341,397 $4,962,781 +0.3%
Net Income $837,109 $512,966 +0.6%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
20
Independent Members
18
Employees
35
Volunteers
487

Governance Policies

✓ Conflict of Interest Policy
✓ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
8
$823,691
Total Directors
21
$823,691
Key Employees
0
$0
Highest Compensated
2
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
ABBA ZUBAIR MD BOARD MEMBER 0.25
Director
$0 $0 $0
ALAN BALCH PHD BOARD MEMBER 0.25
Director
$0 $0 $0
C FRED LEMAISTRE MD PAST PRESIDENT 1.25
Officer Director
$0 $0 $0
CARLOS BACHIER MD SECRETARY 1.25
Officer Director
$0 $0 $0
CARLOS RAMOS MD TREASURER 1.25
Officer Director
$0 $0 $0
CATHERINE BOLLARD MD PRESIDENT 1.25
Officer Director
$0 $0 $0
DANIEL COURIEL MD BOARD MEMBER 0.25
Director
$0 $0 $0
DAVID SCHMAHL CHIEF EXEC OFFICER 40.00
Officer Director
$238,095 $0 $238,095
ELIZABETH SHPALL MD VICE PRESIDENT 1.25
Officer Director
$0 $0 $0
ENEIDA NEMECEK MD BOARD MEMBER 0.25
Director
$0 $0 $0
HUY PHAM MD BOARD MEMBER 0.25
Director
$0 $0 $0
LINDA MILLER MPA CHIEF OPER OFFICER 50.00
Officer Director
$238,038 $0 $238,038
MARY GRABLE MCLEOD BOARD MEMBER 0.25
Director
$0 $0 $0
NADIM MAHMUD MD BOARD MEMBER 0.25
Director
$0 $0 $0
NAVNEET MAJHAIL MD BOARD MEMBER 0.25
Director
$0 $0 $0
NICOLE PROKOPISHYN STANDARDS CHAIR 1.25
Director
$0 $0 $0
PATRICK HANLEY PHD BOARD MEMBER 0.25
Director
$0 $0 $0
PHILLIP JOHNSON BOARD MEMBER 0.25
Director
$0 $0 $0
PHYLLIS WARKENTIN MD CHIEF MED OFFICER 50.00
Officer Director
$347,558 $0 $347,558
SERGIO GIRALT MD BOARD MEMBER 0.25
Director
$0 $0 $0
WANXING CUI MD PHD BOARD MEMBER 0.25
Director
$0 $0 $0
ALISA FORSYTHE DIRECTOR OF TECHNOLOGY SER 40.00
Highest
$130,780 $0 $130,780
JOSEPH SCHWARTZ SENIOR MEDICAL OFFICER 40.00
Highest
$263,000 $0 $263,000
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $7,178,506 $6,341,397 $3,752,677 $837,109
2023 $5,475,747 $4,962,781 $2,915,569 $512,966
2022 $4,719,051 $4,363,156 $2,402,603 $355,895
2021 $3,571,480 $3,205,464 $2,046,708 $366,016
2020 $3,340,959 $2,679,864 $1,680,692 $661,095
2019 $3,319,475 $2,974,036 $1,019,597 $345,439
2018 $2,736,616 $2,748,016 $674,158 $-11,400
Explore More Nonprofits
→Top 100 Nonprofits in Nebraska →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY with other nonprofits in Nebraska and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.